FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.7  |  FHIR Version n/a  User: [n/a]

900000000000526001: REPLACED BY association reference set (foundation metadata concept)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
900000000001156010 REPLACED BY association reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001157018 REPLACED BY association reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)


19439 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
REPLACED BY association reference set (foundation metadata concept) Is a Historical association reference set (foundation metadata concept) true Inferred relationship Some

Members targetComponentId
Oxidase Oxidase
Oxo-acid-lyase Oxo-acid-lyase
Oxybuprocaine 0.4% eye drops Oxybuprocaine only product
Oxybuprocaine hydrochloride 0.4% conventional release eye drops Oxybuprocaine only product
Oxybuprocaine hydrochloride 0.4% single-use eye drops Oxybuprocaine only product
Oxybutynin 3.9mg/day transdermal system Product containing precisely oxybutynin 162 microgram/1 hour prolonged-release transdermal patch (clinical drug)
Oxybutynin hydrochloride 15mg m/r tablet Oxybutynin only product in oral dose form
Oxybutynin hydrochloride 15mg prolonged-release oral tablet Oxybutynin only product in oral dose form
Oxycodone hydrochloride 160mg m/r tablet Product containing only oxycodone in oral dose form (medicinal product form)
Oxycodone hydrochloride 160mg prolonged-release oral tablet Product containing only oxycodone in oral dose form (medicinal product form)
Oxygen enrichment therapy NOS Oxygen enrichment therapy
Oxygen enrichment therapy nos Oxygen enrichment therapy
Oxygenase Oxygenase
Oxymetazoline hydrochloride 0.025% nose drops Oxymetazoline hydrochloride 250 microgram/mL nasal solution
Oxymetazoline hydrochloride 0.05% eye drops Oxymetazoline hydrochloride 500 microgram/mL eye solution
Oxymetazoline hydrochloride 0.05% nose drops Oxymetazoline hydrochloride 500 microgram/mL nasal solution
Oxymorphone 10mg m/r tablet Oxymorphone only product in oral dose form
Oxymorphone 10mg prolonged-release oral tablet Oxymorphone only product in oral dose form
Oxymorphone 20mg m/r tablet Oxymorphone only product in oral dose form
Oxymorphone 20mg prolonged-release oral tablet Oxymorphone only product in oral dose form
Oxymorphone 40mg m/r tablet Oxymorphone only product in oral dose form
Oxymorphone 40mg prolonged-release oral tablet Oxymorphone only product in oral dose form
Oxymorphone 5mg m/r tablet Oxymorphone only product in oral dose form
Oxymorphone 5mg prolonged-release oral tablet Oxymorphone only product in oral dose form
Oxytocin 10unt infusion solution 1mL vial Product containing precisely oxytocin 10 unit/1 milliliter conventional release solution for injection (clinical drug)
Oyster - dietary Oyster (substance)
PEG-intron redipen Product containing peginterferon alfa-2b (medicinal product)
PEG-intron redipen 120micrograms powder+sterile water 0.5mL Interferon alfa-2b (as peginterferon alfa-2b) 120 microgram powder for solution for injection pen
PEG-intron redipen 150micrograms powder+sterile water 0.5mL Interferon alfa-2b (as peginterferon alfa-2b) 150 microgram powder for solution for injection pen
PEG-intron redipen 50micrograms powder+sterile water 0.5mL Interferon alfa-2b (as peginterferon alfa-2b) 50 microgram powder for solution for injection pen
PEG-intron redipen 80micrograms powder+sterile water 0.5mL Interferon alfa-2b (as peginterferon alfa-2b) 80 microgram powder for solution for injection pen
PIE syndrome Löffler's syndrome (disorder)
Packing - action Insertion - action (qualifier value)
Paclitaxel 1mcg/mm drug eluting stent Paclitaxel 1 microgram/mm2 drug eluting stent (product)
Pain of oral cavity structure Pain of region of internal part of mouth (finding)
Painful ejaculation Painful ejaculation
Painting of female perineal warts Painting of perineal warts (procedure)
Palatal flap Flap (substance)
Palatoplasty Uvulopalatopharyngoplasty
Pale faeces Pale feces
Pale faeces Pale feces
Pale feces symptom Pale feces
Pale red color Pale red colour
Pamidronate disodium 3mg/mL infusion concentrate 5mL vial Product containing precisely disodium pamidronate 3 milligram/1 milliliter conventional release solution for injection (clinical drug)
Pancreas excision Pancreatectomy
Pancrelipase, amylase:lipase 183.49mg capsule Amylase and pancrelipase and triacylglycerol lipase only product
Pancrelipase, amylase:lipase 184.84mg capsule Amylase and pancrelipase and triacylglycerol lipase only product
Pancrelipase, amylase:lipase 210.33mg capsule Amylase and pancrelipase and triacylglycerol lipase only product
Pancrelipase, amylase:lipase 278.72% capsule Amylase and pancrelipase and triacylglycerol lipase only product
Pancrelipase, amylase:lipase 312.17mg capsule Amylase and pancrelipase and triacylglycerol lipase only product
Pancrelipase, amylase:lipase 346.86mg capsule Amylase and pancrelipase and triacylglycerol lipase only product
Pancrelipase, amylase:lipase 4500unit capsule Amylase and pancrelipase and triacylglycerol lipase only product
Pancrelipase, amylase:lipase 62.81% Amylase and pancrelipase and triacylglycerol lipase only product
Pancrelipase, amylase:lipase 62.81% capsule Amylase and pancrelipase and triacylglycerol lipase only product
Pancrelipase, amylase:lipase 94.3mg capsule Amylase and pancrelipase and triacylglycerol lipase only product
Pantoprazole sodium 40mg injection Pantoprazole (as pantoprazole sodium) 40 mg powder for solution for injection vial
Pantoprazole sodium 40mg m/r tablet Pantoprazole (as pantoprazole sodium) 40 mg gastro-resistant oral tablet
Pantoprazole sodium 40mg powder Pantoprazole (as pantoprazole sodium) 40 mg powder for solution for injection vial
Pantoprazole sodium 40mg/vial powder for injection Pantoprazole (as pantoprazole sodium) 40 mg powder for solution for injection vial
Papain specific extract Product containing papain (medicinal product)
Papaya - dietary Papaya (substance)
Paphosia adorabilis Lophornis adorabilis (organism)
Papillary cystadenoma, borderline malignancy Papillary cystadenoma, borderline malignancy
Papillary cystic tumour Primary malignant solid pseudopapillary neoplasm of pancreas (disorder)
Papillary mucinous cystadenoma, borderline malignancy Papillary mucinous cystadenoma, borderline malignancy
Papillary serous cystadenocarcinoma Serous cystadenocarcinoma
Papillary serous cystadenoma, borderline malignancy Serous papillary cystic tumour of borderline malignancy
Papilloma, no International Classification of Diseases for Oncology subtype (except papilloma of bladder M-81201) Benign papilloma (morphologic abnormality)
Para-aminophenol derivative anti-inflammatory agent Para-aminophenol derivative
Paracetamol + chlorpheniramine maleate + phenylephrine hydrochloride 500mg/8mg/40mg Product containing only chlorphenamine and paracetamol and phenylephrine (medicinal product)
Paracetamol + orphenadrine citrate 500mg/50mg Orphenadrine and paracetamol only product
Paracetamol - chemical Product containing paracetamol (medicinal product)
Paracetamol 1g/sachet powder Paracetamol only product
Paracetamol 1g/sachet powder Paracetamol only product
Paracetamol 500mg soluble tablet Product containing precisely paracetamol 500 milligram/1 each conventional release effervescent oral tablet (clinical drug)
Paracetamol 650mg / pentazocine hydrochloride 25mg caplet Paracetamol 650 mg and pentazocine 25 mg oral tablet
Paracetamol 650mg / pentazocine hydrochloride 25mg conventional release oral tablet Paracetamol 650 mg and pentazocine 25 mg oral tablet
Paracetamol level abnormal Acetaminophen above therapeutic range
Paracetamol level normal Acetaminophen within therapeutic range
Paracetamol+caffeine 500mg/65mg soluble tablet Product containing precisely caffeine 650 microgram/1 milliliter and paracetamol 5 milligram/1 milliliter conventional release oral solution (clinical drug)
Parafollicular cell carcinoma Medullary thyroid carcinoma
Parafunctional occlusal trauma Secondary occlusal trauma
Parahyaena brunnea Hyaena brunnea (organism)
Paramyxovirus Genus Respirovirus (organism)
Paramyxovirus group Genus Respirovirus (organism)
Paraplegia, brachydactyly, cone-shaped epiphysis syndrome Autosomal recessive spastic ataxia of Charlevoix-Saguenay (disorder)
Parascapular fasciocutaneous flap Fasciocutaneous flap
Parascapular fasciocutaneous flap plus scapula Osteofasciocutaneous flap (substance)
Parasomnia disorder caused by substance Parasomnia
Parathormone Parathyroid hormone
Parathyroid hormone-related peptide-secreting tumor Parathyroid hormone-related peptide-secreting tumor of pancreas (disorder)
Paratyphoid exanthem Eruption of skin caused by Salmonella Paratyphi
Parecoxib 40mg (injection pdr for recon) Parecoxib only product
Parecoxib 40mg injection (pdr for recon)+diluent Parecoxib only product
Parecoxib 40mg injection (pdr for recon)+diluent Parecoxib only product
Parent is handicapped Parent has disability
Parent of subject Parent
Parental reassurance Providing reassurance to parent
Parental reassurance Providing reassurance to parent
Parenteral form anticoagulants Anticoagulant (substance)
Parenteral glyceryl trinitrate allergy Allergy to nitroglycerin

Start Previous Page 118 of 195 Next End


Reference Sets

Reference set descriptor

Back to Start